Abstract
The patient was a 70-year-old male with advanced cancers of stomach and rectum and multiple metastatic hepatic tumors. No resectability was detected. The origin of metastatic hepatic tumors was unknown, so the combination of S- / 1 and CPT-11 as a treatment regimen was selected. S-1, 80 mg m(2), was administered on 14 consecutive days followed / by a 14-day rest period, and CPT-11, 100 mg/m(2), was administered on day 1 and day 15. One cycle was defined as 4 weeks, and cycles were repeated. CR was achieved as long as metastatic hepatic tumors after completion of 5 cycles. When we encounter a case of simultaneous double cancers with metastatic sites which has no respectability, generally speaking, it is difficult to determine the strategy for chemotherapy. This case suggests that the combination of S-1 and CPT-11 may be an effective regimen for the treatment of simultaneous advanced cancers of stomach and rectum with multiple hepatic metastases.
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biopsy
-
Camptothecin / analogs & derivatives*
-
Camptothecin / therapeutic use
-
Carcinoembryonic Antigen / blood
-
Drug Combinations
-
Endoscopy, Gastrointestinal
-
Humans
-
Irinotecan
-
Liver Neoplasms / blood
-
Liver Neoplasms / diagnostic imaging
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / secondary*
-
Male
-
Neoplasms, Multiple Primary / blood
-
Neoplasms, Multiple Primary / drug therapy*
-
Neoplasms, Multiple Primary / pathology*
-
Oxonic Acid / therapeutic use*
-
Rectal Neoplasms / blood
-
Rectal Neoplasms / drug therapy
-
Rectal Neoplasms / pathology
-
Rectal Neoplasms / surgery
-
Stomach Neoplasms / blood
-
Stomach Neoplasms / drug therapy
-
Stomach Neoplasms / pathology
-
Stomach Neoplasms / surgery
-
Tegafur / therapeutic use*
-
Tomography, X-Ray Computed
-
Treatment Outcome
Substances
-
Carcinoembryonic Antigen
-
Drug Combinations
-
S 1 (combination)
-
Tegafur
-
Oxonic Acid
-
Irinotecan
-
Camptothecin